Photocure
Mindre end 1K følgere
PHO
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Investorkonsensus
Photocure is a medical technology company. The company specializes in photodynamic technology solutions. The solutions are used to treat diseases that cause bladder cancer and HPV. The main markets are dermatology and oncology, where the products are used by hospitals and research institutes worldwide. The company was founded in 1993 and is headquartered in Oslo, Norway.
Læs mereMarkedsværdi
-
Aktieomsætning
-
Omsætning
532,58 mio.
EBIT %
-0,14 %
P/E
-
Udbytteafkast, %
-
Finanskalender
4.5
2026
Generalforsamling '26
7.5
2026
Delårsrapport Q1'26
29.7
2026
Delårsrapport Q2'26
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer